London, 22 July 2015: Technavio, the independent tech-focused global research firm, has published a report on the global brachytherapy devices market 2015-2019, which is expected to at a CAGR of 2.88% during 2014-2019.
“Electronic brachytherapy, a new form of brachytherapy, is gaining traction in the treatment of non-melanoma skin cancer. The therapy involves the implantation of a direct X-ray source at the target site, which reduces radiation exposure to surrounding healthy cells,” says Faisal Ghaus, Vice President of Technavio.
“The therapy features radiation shielding requirements comparable to low voltage therapeutic X-ray devices and offers a favorable treatment time.”
Key Market Drivers
- Increase in Incidence of Cancer
- Increased Popularity of Brachytherapy
- Introduction of New Technologies
- Growth in Developing Economies
Key Market Trends
- Increased Popularity of Epimacular Brachytherapy
- Advances in Radiology
- Increased Preference for Less-invasive Procedures
Key Market Vendors
- C.R. Bard Inc.
- Eckert & Ziegler BEBIG SA
- Elekta AB
- Theragenics Corp.
- Varian Medical Systems Inc.
To define the market circumstances in the next 3-4 years, Technavio analysts have conducted in-depth analysis of the impact of market drivers, challenges and trends featuring data on product segmentations, vendor shares, growth rate by revenue and an evaluation of the different buying criteria in the order of importance.
https://www.technavio.com/%3Cp%3EIf%20you%20are%20interested%20in%20more%…
